IL156131A0 - Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors - Google Patents

Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors

Info

Publication number
IL156131A0
IL156131A0 IL15613101A IL15613101A IL156131A0 IL 156131 A0 IL156131 A0 IL 156131A0 IL 15613101 A IL15613101 A IL 15613101A IL 15613101 A IL15613101 A IL 15613101A IL 156131 A0 IL156131 A0 IL 156131A0
Authority
IL
Israel
Prior art keywords
preparation
cell proliferation
proliferation inhibitors
tetrahydropyridine derivatives
tetrahydropyridine
Prior art date
Application number
IL15613101A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL156131A0 publication Critical patent/IL156131A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IL15613101A 2000-12-23 2001-12-21 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors IL156131A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00128487 2000-12-23
PCT/EP2001/015390 WO2002051842A1 (en) 2000-12-23 2001-12-21 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors

Publications (1)

Publication Number Publication Date
IL156131A0 true IL156131A0 (en) 2003-12-23

Family

ID=8170814

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15613101A IL156131A0 (en) 2000-12-23 2001-12-21 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors

Country Status (27)

Country Link
US (1) US6800638B2 (zh)
EP (1) EP1353921B1 (zh)
JP (1) JP2004516325A (zh)
KR (1) KR100836545B1 (zh)
CN (1) CN1213046C (zh)
AR (1) AR035513A1 (zh)
AT (1) ATE323700T1 (zh)
AU (1) AU2002226397B2 (zh)
BG (1) BG107935A (zh)
BR (1) BR0116402A (zh)
CA (1) CA2431471A1 (zh)
CZ (1) CZ20031940A3 (zh)
DE (1) DE60118975T2 (zh)
EC (1) ECSP034664A (zh)
ES (1) ES2261519T3 (zh)
HU (1) HUP0400554A2 (zh)
IL (1) IL156131A0 (zh)
MA (1) MA26976A1 (zh)
MX (1) MXPA03005713A (zh)
NO (1) NO20032830L (zh)
NZ (1) NZ526189A (zh)
PL (1) PL365531A1 (zh)
RU (1) RU2276140C2 (zh)
SK (1) SK9122003A3 (zh)
WO (1) WO2002051842A1 (zh)
YU (1) YU48803A (zh)
ZA (1) ZA200304264B (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706686B2 (en) 2001-09-27 2004-03-16 The Regents Of The University Of Colorado Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
EP2269609A3 (en) 2001-10-16 2012-07-11 Sloan-Kettering Institute for Cancer Research Treatment of neurodegenerative diseases and cancer of the brain with SAHA
AU2003218508A1 (en) 2002-04-01 2003-10-13 Ranko Rakanovic Rubber elastic element
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
AU2003900608A0 (en) * 2003-02-11 2003-02-27 Fujisawa Pharmaceutical Co., Ltd. Hdac inhibitor
JP2006520796A (ja) 2003-03-17 2006-09-14 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼインヒビター
WO2004113336A1 (en) * 2003-06-16 2004-12-29 Chroma Therapeutics Limited Carboline and betacarboline derivatives for use as hdac enzyme inhibitors
EP1694329A4 (en) * 2003-11-26 2009-06-03 Aton Pharma Inc DIAMOND AND IMINODIACETIC ACID HYDROXAMINIC DERIVATIVES
WO2005065681A1 (en) * 2003-12-19 2005-07-21 Takeda San Diego, Inc. N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer
US20050137234A1 (en) * 2003-12-19 2005-06-23 Syrrx, Inc. Histone deacetylase inhibitors
EP1824831A2 (en) 2004-12-16 2007-08-29 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7772245B2 (en) 2005-02-14 2010-08-10 Miikana Therapeutics, Inc. Inhibitors of histone deacetylase
GB0509223D0 (en) * 2005-05-05 2005-06-15 Chroma Therapeutics Ltd Enzyme inhibitors
WO2006122319A2 (en) 2005-05-11 2006-11-16 Takeda San Diego, Inc. Histone deacetylase inhibitors
JP2009501236A (ja) * 2005-07-14 2009-01-15 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
WO2007084390A2 (en) * 2006-01-13 2007-07-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス，インコーポレイティド ４−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
TWI425945B (zh) * 2007-05-28 2014-02-11 Seldar Pharma Inc 四氫異喹啉－１－酮衍生物或其鹽
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2456757B1 (en) * 2009-07-22 2019-05-01 The Board of Trustees of the University of Illionis Hdac inhibitors and therapeutic methods using the same
CN102153549B (zh) * 2010-12-14 2012-11-14 华东理工大学 γ咔啉化合物、制备方法和用途
JP6117430B2 (ja) 2013-04-29 2017-04-19 チョン クン ダン ファーマシューティカル コーポレーション 選択的ヒストン脱アセチル化酵素抑制剤としての新規化合物およびこれを含む薬剤学的組成物
EP3052662B1 (en) 2013-10-01 2019-05-15 The J. David Gladstone Institutes Compositions, systems and methods for gene expression noise drug screening and uses thereof
CN108084178B (zh) * 2018-01-04 2020-09-01 济南大学 一类含有四氢-β-咔碄结构的异羟肟酸类化合物的用途
CN108558653A (zh) * 2018-05-14 2018-09-21 湖南华腾制药有限公司 赛乐西帕中间体及赛乐西帕的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002119A1 (en) * 1988-08-18 1990-03-08 Banyu Pharmaceutical Co., Ltd. 1,2,3,4-tetrahydroisoquinoline derivatives
US5369108A (en) 1991-10-04 1994-11-29 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
WO1998007421A1 (fr) * 1996-08-16 1998-02-26 Ishihara Sangyo Kaisha, Ltd. Composition medicinale
WO1998015525A1 (fr) 1996-10-07 1998-04-16 Sumitomo Pharmaceuticals Co., Ltd. Acides hydroxamiques
AUPO721997A0 (en) * 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds
US6465468B1 (en) * 1999-03-22 2002-10-15 Darwin Discovery Limited Hydroxamic and carboxylic acid derivatives

Also Published As

Publication number Publication date
MA26976A1 (fr) 2004-12-20
CZ20031940A3 (cs) 2003-10-15
ES2261519T3 (es) 2006-11-16
ATE323700T1 (de) 2006-05-15
BR0116402A (pt) 2003-11-11
HUP0400554A2 (hu) 2004-06-28
AU2002226397B2 (en) 2006-10-05
MXPA03005713A (es) 2003-10-06
NO20032830L (no) 2003-08-04
YU48803A (sh) 2006-05-25
ECSP034664A (es) 2003-07-25
CN1213046C (zh) 2005-08-03
KR100836545B1 (ko) 2008-06-10
CN1483033A (zh) 2004-03-17
PL365531A1 (en) 2005-01-10
CA2431471A1 (en) 2002-07-04
RU2276140C2 (ru) 2006-05-10
JP2004516325A (ja) 2004-06-03
BG107935A (bg) 2004-08-31
NZ526189A (en) 2004-10-29
RU2003122190A (ru) 2005-02-27
DE60118975T2 (de) 2006-12-21
EP1353921A1 (en) 2003-10-22
ZA200304264B (en) 2004-08-30
KR20030063424A (ko) 2003-07-28
DE60118975D1 (de) 2006-05-24
US6800638B2 (en) 2004-10-05
AR035513A1 (es) 2004-06-02
EP1353921B1 (en) 2006-04-19
NO20032830D0 (no) 2003-06-20
SK9122003A3 (en) 2004-02-03
US20040053960A1 (en) 2004-03-18
WO2002051842A1 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
IL156131A0 (en) Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
HUP0200355A2 (en) 4-aminopyrrolopyrimidines as kinase inhibitors, pharmaceutical compositions containing them and their use
HUP0301722A3 (en) Pyrimidine derivatives, pharmaceutical compositions containing them and their use
PT1296974E (pt) Derivados 2-cianopirrolidina e sua utilização como medicamentos
HUP0303069A3 (en) Imidazole derivatives, pharmaceutical compositions containing them and their use
HUP0201633A2 (en) Alpha-aminosulphonyl-acetohydroxamic acid derivatives with metalloprotease inhibiting effect, preparation and use thereof
HUP0202682A3 (en) Tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
HK1048999A1 (zh) 氮雜䓬吲衍生物，它們的製備和應用
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
MXPA03009132A (es) Alquilhidroxamatos triciclicos, su preparacion y su uso como inhibidores de la proliferacion de celulas.
HUP0302997A3 (en) Phenylalanine derivatives with alpha4-integrin effect, pharmaceutical compositions containing them and their use
MXPA03004794A (es) Derivados de acido mandelico y su uso como inhibidores de trombina.
HUP0302959A3 (en) Non-imidazole aryloxyalkylamines, pharmaceutical compositions containing them and their use
HUP0300909A3 (en) 2-guanidino-4-arylchinazolines as nhe-3 inhibitors, pharmaceutical compositions containing them and their use
HUP0203288A3 (en) Pyrrole derivatives as phosphodiesterase vii inhibitors, pharmaceutical compositions containing them and their use
HUP0300578A3 (en) Alkylated imidazopyridine derivatives, pharmaceutical compositions containing them and their use
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
IL135451A0 (en) 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
HUP0204354A3 (en) Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same and their use
PL349769A1 (en) New amidinobenzylamine derivatives and their use as thrombin inhibitors
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
PL352432A1 (en) Neurothrophic pyrolydines and piperidines, their affinite composition and methods of using them
AU5693101A (en) New thiochromane derivatives and their use as thrombin inhibitors